Form 4 for BSX Boston Scientific
Accepted 2021-08-06 00:00:00 ET · period of report 2021-08-05 · accession 0001225208-21-011304 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-08-06 | 2021-08-05 | BSX | Thepaut Eric Francis Yves | EVP, Pres, Eur, Mid-East, Afr | S - Sale | $44.14 | -41.7K | 66.1K | -39% | -$1.84M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-08-05 | S | D | 41,741 | $44.14 | 66,128.99 | D | — | — | (F1) Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $44.10 to $44.18, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |